Trials / Completed
CompletedNCT01497951
Photodynamic Therapy for Oral Precursor Lesions
A Randomized Controlled Trial: Photodynamic Treatment for the Therapy of Premalignant Mucosal Oral Lesions.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- Medical University of Vienna · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Pre-malignant lesions are difficult to treat. Even after surgical removal they tend to re-appear. Often the lesions are to large and are apparent on many sites, therefore surgical removal is not always possible. The photodynamic therapy uses a special substance, which is absorbed in cells, and thereafter activated by a defined light. The aim of this study is to compare the photodynamic therapy in potentially malignant lesions to a placebo. The investigators assume a significant better result in photodynamic therapy then treatment with a placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Aminolaevulinic acid | Photodynamic therapy |
| OTHER | Methylcellulose Placebo | Methylcellulose |
Timeline
- Start date
- 2011-05-01
- Primary completion
- 2017-01-01
- Completion
- 2017-01-01
- First posted
- 2011-12-23
- Last updated
- 2017-05-17
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT01497951. Inclusion in this directory is not an endorsement.